Anixa Biosciences, Inc. is a Los Angeles-based biotechnology company dedicated to the development of innovative therapies and vaccines for cancer treatment and prevention. Specializing in utilizing the body's immune system, Anixa focuses on addressing critical unmet needs in oncology through cutting-edge technologies such as CAR-T cell therapy and cancer vaccines.
The company's pipeline includes revolutionary approaches like the development of a breast cancer vaccine targeting triple negative breast cancer, as well as an ovarian cancer vaccine aimed at preventing the occurrence of this disease. With a strong emphasis on research and development, Anixa Biosciences is at the forefront of advancing immunotherapy solutions in the fight against cancer.
Generated from the website